SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-086662
Filing Date
2023-11-14
Accepted
2023-11-14 13:01:05
Documents
57
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0923_biomxinc.htm   iXBRL 10-Q 566913
2 FORM OF INDEMNIFICATION AGREEMENT f10q0923ex10-2_biomxinc.htm EX-10.2 80132
3 CERTIFICATION f10q0923ex31-1_biomxinc.htm EX-31.1 8073
4 CERTIFICATION f10q0923ex31-2_biomxinc.htm EX-31.2 8247
5 CERTIFICATION f10q0923ex32_biomxinc.htm EX-32 6114
  Complete submission text file 0001213900-23-086662.txt   3912217

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE phge-20230930.xsd EX-101.SCH 52212
7 XBRL CALCULATION FILE phge-20230930_cal.xml EX-101.CAL 33062
8 XBRL DEFINITION FILE phge-20230930_def.xml EX-101.DEF 200173
9 XBRL LABEL FILE phge-20230930_lab.xml EX-101.LAB 425692
10 XBRL PRESENTATION FILE phge-20230930_pre.xml EX-101.PRE 212625
51 EXTRACTED XBRL INSTANCE DOCUMENT f10q0923_biomxinc_htm.xml XML 349986
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38762 | Film No.: 231403408
SIC: 2836 Biological Products, (No Diagnostic Substances)